Annual Cash & Cash Equivalents
$19.80 M
+$7.07 M+55.49%
December 31, 2023
Summary
- As of February 8, 2025, UBX annual cash & cash equivalents is $19.80 million, with the most recent change of +$7.07 million (+55.49%) on December 31, 2023.
- During the last 3 years, UBX annual cash & cash equivalents has risen by +$2.00 million (+11.21%).
- UBX annual cash & cash equivalents is now -77.82% below its all-time high of $89.29 million, reached on December 31, 2016.
Performance
UBX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.90 M
+$1.31 M+17.33%
September 30, 2024
Summary
- As of February 8, 2025, UBX quarterly cash and cash equivalents is $8.90 million, with the most recent change of +$1.31 million (+17.33%) on September 30, 2024.
- Over the past year, UBX quarterly cash and cash equivalents has increased by +$1.02 million (+12.98%).
- UBX quarterly cash and cash equivalents is now -85.82% below its all-time high of $62.75 million, reached on March 31, 2018.
Performance
UBX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
UBX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.5% | +13.0% |
| 3 y3 years | +11.2% | -30.1% |
| 5 y5 years | +28.6% | -30.1% |
UBX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.8% | +55.5% | -73.0% | +19.8% |
| 5 y | 5-year | -47.1% | +55.5% | -81.7% | +19.8% |
| alltime | all time | -77.8% | +171.3% | -85.8% | +21.9% |
Unity Biotechnology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.90 M(+17.3%) |
| Jun 2024 | - | $7.58 M(+2.1%) |
| Mar 2024 | - | $7.43 M(-62.5%) |
| Dec 2023 | $19.80 M(+55.5%) | $19.80 M(+151.4%) |
| Sep 2023 | - | $7.88 M(-58.8%) |
| Jun 2023 | - | $19.12 M(-16.8%) |
| Mar 2023 | - | $22.97 M(+80.4%) |
| Dec 2022 | $12.74 M(-61.3%) | $12.74 M(-43.6%) |
| Sep 2022 | - | $22.58 M(+16.1%) |
| Jun 2022 | - | $19.44 M(+18.2%) |
| Mar 2022 | - | $16.45 M(-50.0%) |
| Dec 2021 | $32.91 M | $32.91 M(+49.6%) |
| Sep 2021 | - | $21.99 M(+62.9%) |
| Jun 2021 | - | $13.50 M(-49.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $26.84 M(+50.7%) |
| Dec 2020 | $17.81 M(-52.5%) | $17.81 M(-63.3%) |
| Sep 2020 | - | $48.58 M(+22.7%) |
| Jun 2020 | - | $39.59 M(+58.0%) |
| Mar 2020 | - | $25.06 M(-33.1%) |
| Dec 2019 | $37.47 M(+143.3%) | $37.47 M(+1.9%) |
| Sep 2019 | - | $36.77 M(+59.1%) |
| Jun 2019 | - | $23.11 M(-32.5%) |
| Mar 2019 | - | $34.25 M(+122.4%) |
| Dec 2018 | $15.40 M(+111.0%) | $15.40 M(-46.7%) |
| Sep 2018 | - | $28.90 M(-15.4%) |
| Jun 2018 | - | $34.16 M(-45.6%) |
| Mar 2018 | - | $62.75 M(+759.9%) |
| Dec 2017 | $7.30 M(-91.8%) | $7.30 M |
| Dec 2016 | $89.29 M | - |
FAQ
- What is Unity Biotechnology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Unity Biotechnology?
- What is Unity Biotechnology annual cash & cash equivalents year-on-year change?
- What is Unity Biotechnology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Unity Biotechnology?
- What is Unity Biotechnology quarterly cash and cash equivalents year-on-year change?
What is Unity Biotechnology annual cash & cash equivalents?
The current annual cash & cash equivalents of UBX is $19.80 M
What is the all time high annual cash & cash equivalents for Unity Biotechnology?
Unity Biotechnology all-time high annual cash & cash equivalents is $89.29 M
What is Unity Biotechnology annual cash & cash equivalents year-on-year change?
Over the past year, UBX annual cash & cash equivalents has changed by +$7.07 M (+55.49%)
What is Unity Biotechnology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of UBX is $8.90 M
What is the all time high quarterly cash and cash equivalents for Unity Biotechnology?
Unity Biotechnology all-time high quarterly cash and cash equivalents is $62.75 M
What is Unity Biotechnology quarterly cash and cash equivalents year-on-year change?
Over the past year, UBX quarterly cash and cash equivalents has changed by +$1.02 M (+12.98%)